Home › Multiple Myeloma › Virginia › Arlington

Pag-aaral pangklinika para sa Multiple Myeloma sa Arlington, VA

9 pag-aaral para sa Multiple Myeloma ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Arlington (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma

Nagre-recruitPhase 1

Virginia Cancer Specialists - Fairfax /ID# 268559, Fairfax · 11 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 10, 2026 · NCT05650632

AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Multiple Myeloma

Nagre-recruitPhase 1/2

Research Site, Fairfax · 11 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 30, 2026 · NCT06106945

A Study to Assess A Change in Disease Activity and Adverse Events of Intravenous Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Adult Participants With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant

Nagre-recruitPhase 2/3

Virginia Cancer Specialists - Fairfax /ID# 278716, Fairfax · 11 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 19, 2026 · NCT07095452

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

Nagre-recruitPhase 2

Inova Schar Cancer Institute, Fairfax · 11 mi ang layo

Edad 12 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT02693535

Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT

Nagre-recruitPhase 3

Research Site, Fairfax · 11 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 14, 2026 · NCT07764978

Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma

Nagre-recruitPhase 2

Virginia Cancer Specialists, Fairfax · 11 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Abr 22, 2026 · NCT05972135

A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)

Nagre-recruitPhase 3

GSK Investigational Site, Fairfax · 11 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Abr 22, 2026 · NCT06679101

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

Nagre-recruitPhase 1/2

Virginia Cancer Specialists, Fairfax · 11 mi ang layo

Edad 12 pataas · Lahat ng kasarian · Na-update Mar 24, 2026 · NCT04988555

IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers

Nagre-recruitPhase 1/2

NEXT Oncology Virginia, Fairfax · 11 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 3, 2025 · NCT06119685

Pag-aaral para sa Multiple Myeloma sa ibang lungsod

Iba pang pag-aaral sa Arlington

Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.